Home » Archive

Articles tagged with: Mother-To-Child Transmission

Headline, News »

[ by | Feb 8, 2012 10:35 am | Comments Off ]
HIV Severity May Influence Mental Health And Academic Ability In HIV-Positive Teens

Results from a recent study suggest that HIV severity is associated with the severity of some mental health problems and academic, cognitive, and social impairments in teens born with HIV.

The researchers noted that this study alone does not allow conclusions to be drawn about the causes of the associations identified in the study. However, they argued that their results suggested that certain developmental and academic problems are common in children and teens with HIV, even well-controlled HIV.

“Low CD4 percentage at a young age and high viral load at …

Read the full story »

Headline, News »

[ by | Jan 13, 2012 11:16 am | Comments Off ]
HIV-Positive Children And Children Exposed To HIV Are Prone To Language Impairments

Results from a recent study indicate that HIV-positive children and children exposed to HIV during pregnancy are more likely to have language impairments than HIV-negative children.

“Our results show that children exposed to HIV have more than twice the chance of having a language impairment than do children in the general population,” said Dr. George K. Siberry, of the Pediatric, Adolescent and Maternal AIDS Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, in a press release.

However, the study authors also pointed that the …

Read the full story »

Headline, News »

[ by | Nov 18, 2011 11:26 am | Comments Off ]
Exposure To Antiretrovirals During Pregnancy Does Not Alter Bone Development Of Infants

Results from a recent small Italian study indicate that exposure to antiretroviral drugs, including Viread, during pregnancy does not affect fetal bone metabolism and bone development.

“Antiretroviral therapy taken during pregnancy is not detrimental to bone development and bone health of the fetus/infant. Due to the awareness about the numerous side effects of antiretrovirals, we wanted to verify the safety for the fetus of the therapy,” said Dr. Stefano Mora from the Laboratory of Pediatric Endocrinology at the San Raffaele Scientific Institute of Milan, Italy, and lead author of the …

Read the full story »

Featured, Headline, News »

[ by | Nov 3, 2011 12:51 pm | Comments Off ]
HAART More Than Doubles The Survival Rate Of Children With HIV

Results of a recent study show that the 10-year survival rates for children born with HIV who receive highly active antiretroviral therapy are more than double those for children who do not. As a result, survival rates have improved dramatically over the past two decades.

Most (84 percent) of the children in the study who did not survive were born before 1994, at least three years before highly active antiretroviral therapy (HAART) became widely available.

“As antiretroviral utilization milestones were achieved throughout the course of this study, in going from …

Read the full story »

News »

[ by | Sep 19, 2011 10:40 am | Comments Off ]

Short-Course Incivek-Containing Therapy Is Effective For Most People With Untreated Hepatitis C – Results of a Phase 3 clinical trial show that for people with previously untreated hepatitis C who respond well to treatment with Incivek (telaprevir), Pegasys (peginterferon alfa-2a), and ribavirin (Copegus, Rebetol), a 24-week course of treatment is as effective as a 48-week course. Among the study participants who had undetectable hepatitis C virus levels after 4 and 12 weeks of treatment, 92 percent who received 20 weeks of treatment with the three-drug combination followed by 4 more weeks of Pegasys and ribavirin treatment (24 weeks total) were cured of hepatitis C, compared to 88 percent of participants who received 20 weeks of the three-drug combination followed by 28 weeks of the two-drug combination (48 weeks total). For more information, please see the article in U.S. News & World Report or the study in the New England Journal of Medicine (abstract).

Office Of National AIDS Policy To Hold Discussions On National HIV/AIDS Strategy – The Office of National AIDS Policy is planning to hold several discussions with members of the HIV community, including researchers, clinicians, and people with HIV, on implementation of the National HIV/AIDS Strategy. The first talk will be at the University of Alabama in Birmingham on September 27 and is entitled “Incorporation of Prevention and Care Research Into HIV Programs.” Additional talks will be held October 4 in Seattle; October 20 in Philadelphia; late October in Baton Rouge, LA (date to be decided); and early November in Des Moines, IA (date to be decided). Additional dates and locations will be announced later. For more information, please see the AIDS.gov website.

Atlanta Police Department Sued For Discriminating Against HIV-Positive Man – An HIV-positive man who was denied a job as a police officer in Atlanta after a pre-employment medical exam revealed his HIV status has sued the city of Atlanta for discrimination. The man claims that the city violated the Americans with Disabilities Act (ADA) and other federal and state laws; HIV is considered a protected illness under the ADA. Atlanta claims that the man was rejected for reasons other than his HIV status, but that they were also justified in not hiring him because his status represents a “direct threat” to the health and safety of others. For more information, please see the article in The GA Voice.

AIDS Institute Releases New Guidelines On HIV Testing And Treatment During Pregnancy – New York’s AIDS Institute has released two new guides, “HIV Testing During Pregnancy and at Delivery” and “Acute HIV Infection in Pregnancy.” The guides are the first two sections of a new set of guidelines on managing HIV infection in pregnant women. The remaining sections will be posted as they are completed. The guidelines are being formulated in cooperation with the Johns Hopkins University Division of Infectious Diseases. For more information, please see the HIV Testing During Pregnancy and at Delivery and Acute HIV Infection in Pregnancy guidelines.